Hofseth Biocare sees “accelerating sales mix” in Q1 despite COVID-19 disruptions

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

26 May 2020 --- Hofseth BioCare (HBC) is entering into a Phase 2 clinical trial to assess the ability of OmeGo salmon oil to reduce Acute Respiratory Distress Syndrome (ARDS)... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

12 May 2020 --- After over a decade of development, Hofseth Biocare (HBC) has “perfected” the formula for its ProGo salmon protein hydrolysate (SPH) for weight... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Apr 2020 --- Global upheaval as cases of COVID-19 reach the million-mark has seen revitalized consumer interest in immunity. Activity in this space has flourished as people look... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

20 Mar 2020 --- In nutrition news this week, Monteloeder took a multifaceted approach to its North American expansion, while Prinova Europe will now distribute Hofseth BioCare... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

09 Dec 2019 --- According to the World Health Organization (WHO), by 2050 the global population of people over the age of 60 is forecasted to more than double to two billion. The... Read More

trans